HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Factitious Disorders (Ganser Syndrome)

Subscribe to New Research on Factitious Disorders

Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural.

Also Known As:

Ganser Syndrome; Pseudodementia; Disorders, Factitious; Syndrome, Ganser; Pseudopsychosis

Networked: 32 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Disease Context: Research Results

Mental Disorders: 2989
- Factitious Disorders: 32
  - Munchausen Syndrome: 28

Related Diseases

1.	Dementia (Dementias)
2.	Depressive Disorder (Melancholia)
3.	Pain (Aches)
4.	Bipolar Disorder (Mania)
5.	Pseudobulbar Palsy

Experts

1.	Masel, Eva K: 1 article (12/2015)
2.	Porstner, Dagmar: 1 article (12/2015)
3.	Heck, Ursula: 1 article (12/2015)
4.	Inamoto, Atsuko: 1 article (01/2015)
5.	Tani, Masayuki: 1 article (01/2015)
6.	Hori, Koji: 1 article (01/2015)
7.	Kitajima, Yuka: 1 article (01/2015)
8.	Hosoi, Misa: 1 article (01/2015)
9.	Hachisu, Mitsugu: 1 article (01/2015)
10.	Izuno, Takuji: 1 article (01/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Factitious Disorders:

1.	Dexamethasone (Maxidex)FDA LinkGeneric 04/01/1982 - "The dexamethasone suppression test in two patients with severe depressive pseudodementia." 02/01/1983 - "It seems likely that many of the affective syndromes in the elderly like senile melancholia, manic depressive illness, pseudodementia, and masked depression belong to the group of endogenous depressions, and can be identified by a constellation of clinical symptoms (endogenous or endogenomorphic profile), abnormal dexamethasone suppression test (DST) (at least 50%), and positive response to treatment with antidepressant medication. "
2.	Ibuprofen (Motrin)FDA LinkGeneric 01/01/2003 - "Pseudodementia associated with use of ibuprofen." 01/01/2003 - "Using the Naranjo probability scale, we reasoned that the patient's dementia-like syndrome could be attributed to the use of ibuprofen because pseudodementia appeared after the suspected drug was administered, improved when the drug was discontinued, reappeared when the drug was readministered, had no apparent alternative cause, manifested similarly after each exposure to ibuprofen, and was confirmed by the family's observation after both episodes. "
3.	Sertraline (Zoloft)FDA LinkGeneric 08/01/2011 - "She was initially treated with memantine, but as time progressed it became more evident she was experiencing depression and a "pseudodementia," which was treated with sertraline. " 01/01/2001 - "Sertraline and reboxetine association in depressive pseudodementia: good cardiovascular effects."
4.	PlasticsIBA 02/01/2009 - "The plastic surgeon rarely encounters patients with factitious disorders. " 01/01/2008 - "We outline clues to the recognition of factitious disorders and steps the plastic surgeon can take to initiate appropriate treatment, which may reduce the risk of litigation." 01/01/2008 - "Factitious disorders: potential litigation risks for plastic surgeons."
5.	tebufenozide (Mimic)IBA 03/01/1997 - "First, although parkinsonism is known to be preceded by depressive episodes, particularly in a subgroup of younger patients, the symptoms of the elderly patient whose Parkinson's disease is foreshadowed by depression can mimic depressive pseudodementia, potentially leading to diagnostic confusion. " 01/01/1985 - "The term pseudodementia is applied to the range of functional psychiatric conditions such as depression, schizophrenia and hysteria that may mimic organic dementia, but are essentially reversible on treatment. "
6.	antineoplaston A10 (A 10)IBA 03/01/1989 - "A case of pseudodementia in a 10 year old boy was first reported in 1981. " 03/01/1989 - "Ganser syndrome in a 10 year old boy--an 8 year follow up." 12/01/1981 - "A case of pseudodementia, occurring in a 10 year old boy following a minor head injury and associated with a claim for compensation, is presented. "
7.	Technetium Tc 99m Exametazime (Ceretec)FDA Link 05/01/2002 - "Through the comparison of the 99mTc-HMPAO single photon emission computed tomography (SPECT) image of depressive pseudodementia subjects, healthy comparison subjects, depressed subjects free of cognitive impairment, and dementia of Alzheimer's type (DAT) subjects, we aimed to see part of pathophysiology of the depressive pseudodementia of elderly patients. "
8.	Biological Markers (Surrogate Marker)IBA 12/01/1995 - "CSF-tau and CSF-PHFtau may therefore be useful as a positive biochemical marker, to discriminate AD from normal aging, PD, and depressive pseudodementia. "
9.	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/01/2000 - "Pseudodementia in a twenty-one-year-old with bipolar disorder and vitamin B12 and folate deficiency."
10.	Psychotropic Drugs (Psychoactive Drugs)IBA 11/01/1987 - "Pseudodementia accompanying major depression and chronic cognitive dysfunction due to psychoactive drugs are among the most commonly missed diagnoses. "

Therapies and Procedures

1.	Aftercare (After-Treatment) 01/01/1995 - "Long-term cognitive changes were observed in 8 depressed patients whose pretreatment cognitive impairment (depressive dementia or pseudodementia) resolved after treatment with ECT. " 04/01/1989 - "We found significant group differences on waking EEGs between those mixed patients who did well after treatment for depression (depressive pseudodementia) compared to patients having dementia with secondary depression. " 04/08/1996 - "[Prolonged pseudodementia after treatment with tricyclic antidepressive agents and electroconvulsive therapy]."
2.	Catheters 12/01/1993 - "The remaining clinical scenarios included intravenous catheter sepsis and factitious disorders. "
3.	Palliative Care (Palliative Medicine) 12/01/2015 - " question of this case report is, how a palliative care specialist can distinguish between a malignant disease or neurological disease progression and a presentation primarily psychiatric in etiology, as is the case in factitious disorders. "
4.	Electric Stimulation Therapy (Electrotherapy) 11/04/1991 - "Dementia contra depression-induced pseudodementia and electric stimulation therapy of depressed patients with epilepsy]."
5.	Drug Therapy (Chemotherapy) 02/01/2003 - "Appropriate indications for PEG placement are 1) Esophageal obstruction (e.g., esophageal cancer), 2) Neurologic etiology of dysphagia without obstruction (e.g., status post cerebrovascular accident, pseudobulbar palsy), 3) Prolonged refusal to swallow without evidence of concomitant terminal illness (e.g., protracted pseudodementia due to severe depression), 4) Supplemental nutrition for patients undergoing chemotherapy or radiation therapy. "